Smallpox Response Plan and Guidelines (Version 3.0)
November 26, 2002 - The CDC Smallpox Response Plan and Guidelines (Guides A-F plus Annex files 1-8) were last updated on September 23, 2002. On November 26, 2002, all of the forms within Guide A were updated to Version 3.0. (note 1)
This document outlines the public health strategies that would guide the public health response to a smallpox emergency and many of the federal, state, and local public health activities that must be undertaken in a smallpox outbreak.
Title |
|||
---|---|---|---|
Cover Page (includes contact information) | view (72 KB/2 pages) |
view (120 KB/2 pages) |
|
Table of Contents | view (112 KB/2 pages) |
view (32 KB/2 pages) |
|
Executive Summary plus Sections A through F (Includes: criteria for implementation of CDC smallpox response plan; notification procedures for suspected smallpox cases; CDC and state/local responsibilities and action in the event of a smallpox outbreak; vaccine mobilization and deployment; and CDC personnel mobilization and deployment, etc.) | view (237 KB/10 pages) |
view (121 KB/10 pages) |
|
Draft Guide ASmallpox Surveillance and Case Reporting; Contact Identification, Tracing, Vaccination, and Surveillance; and Epidemiologic Investigation (Includes: pre-event rash surveillance; smallpox clinical case description and differential diagnosis; smallpox case definitions and classifications; post-event response epidemiological investigation; post-event surveillance; contact identification, tracing and surveillance; description of Smallpox Post-Event Surveillance Forms, etc.) (note 2) |
|||
Draft Guide A (Case definition [section III] was updated on Dec 31, 2003) |
view (589 KB/31 pages) |
view (471 KB/31 pages) |
|
Overview of forms | view (126 KB/3 pages) |
||
Draft Appendix 16 (Includes: Using forms and worksheets for contact identification, tracing, vaccination, and surveillance) |
view (119 KB/5 pages) |
||
Complete Workflow with Forms | view forms (102 KB/5 pages) |
||
Form 1 Post-Event Surveillance Version 3.0 Please note the following major changes in Form 1: Laboratory confirmation, and smallpox case classifications and clinical types |
view form (148 KB/2 pages) |
view instructions (61 KB/8 pages) |
|
Form 2a Case Travel/Activity Worksheet—Infectious Period Version 3.0 | view form (80 KB/1 page) |
view instructions (167 KB/4 pages) |
|
Form 2b Primary Contact/Site Worksheet Version 3.0 Please note the following major changes in Form 2b: contact priority codes 1-5 |
view form (101 KB/1 page) |
view instructions (167 KB/4 pages) |
|
Form 2c Contact Transportation Worksheet—Infectious Period Version 3.0 | view form (110 KB/1 page) |
view instructions (167 KB/4 pages) |
|
Form 2d Contact Tracing Version 3.0 | view form (399 KB/1 page) |
view instructions (163 KB/5 pages) |
|
Form 2e Case Household and Primary Contact Surveillance Version 3.0 Please note the following major changes in Form 2e: New form for primary contact surveillance | view form (117 KB/1 page) |
view instructions (125 KB/2 pages) |
|
Form 2f Case Primary Contact's Household Members Surveillance Version 3.0 Please note the following major changes in Form 2f: New form for secondary contact surveillance | view form (71 KB/1 page) |
view instructions (98 KB/2 pages) |
|
Form 3a Case Exposure Investigation Version 3.0 | view form (205 KB/2 pages) |
view instructions (131 KB/4 pages) |
|
Form 3b Case Travel/Activity Worksheet—Exposure Period Version 3.0 | view form (95 KB/1 page) |
view instructions (131 KB/4 pages) |
|
Form 3c Case Transportation Worksheet—Exposure Period Version 3.0 | view form (110 KB/1 page) |
view instructions (131 KB/4 pages) |
|
Guide B—Vaccination Guidelines for State and Local Health Agencies (Includes: vaccination guidelines, vaccination strategies, indications for vaccination, contraindications for vaccination, reconstitution, administration, and storage of vaccine, recognition of expected vaccine reactions/take, recognition of adverse reactions, indications and guidelines for VIG administration, etc.) |
|||
Part 1 | view (145 KB/7 pages) |
view (119 KB/7 pages) |
|
Part 2 | view (267 KB/9 pages) |
view (757 KB/9 pages) |
|
Part 3 | view (427 KB/5 pages) |
view (658 KB/5 pages) |
|
Guide C—Infection Control Measures for Healthcare and Community Settings and Quarantine Guidelines | |||
Part 1 Infection Control Measures for Healthcare and Community Settings |
view (236 KB/14 pages) |
view (176 KB/14 pages) |
|
Part 2 Quarantine Guidelines |
view (174 KB/8 pages) |
view (245 KB/8 pages) |
|
Guide D—Specimen Collection and Transport Guidelines (Includes: specimen collection supply list; procedure for patients with vesicles or pustules; procedure for patients with scab lesions; autopsy specimens; packing and labeling of specimens, etc.) |
|||
Specimen Collection and Transport Guidelines | view (239 KB/12 pages) |
view (128 KB/12 pages) |
|
Guide E—Communications Plans and Activities (Includes: overall communication plan purpose; overall smallpox plan objectives; guiding principles; pre-event and post-event activities, etc.) |
|||
Communications Plans & Activities | view (581 KB/29 pages) |
view (731 KB/29 pages) |
|
Guide F—Environmental Control of Smallpox Virus (Includes: use of current medical decontamination protocols utilizing low- to intermediate-level chemical germicides or EPA-registered detergent disinfectants for the cleaning of surfaces potentially contaminated with smallpox virus) |
|||
Environmental Control of Smallpox Virus | view (227 KB/10 pages) |
view (71 KB/10 pages) |
|
Annex Files (1-10) | |||
Annex 1—Overview of Smallpox and Clinical Presentations, and Medical Care of Smallpox Patient (19 pages total, due to number of images broken into 3 sections) |
view (820 KB/pages 1-9) |
view (944 KB/pages 1-9) |
|
view (183 KB/pages 10-16) |
view (176 KB/pages 10-16) |
||
view (261 KB/pages 17-19) |
view (250 KB/pages 17-19) |
||
Annex 2—General Guidelines for Smallpox Vaccination Clinics | view (146 KB/24 pages) |
view (325 KB/24 pages) |
|
Annex 3—Guidelines for Large Scale Smallpox Vaccination Clinics (Logistical Considerations and Guidance for State and Local Planning for Emergency, Large-Scale, Voluntary Administration of Smallpox Vaccine in Response to a Smallpox Outbreak. Also provides details on all aspects of immunization clinic operations and staffing with an example of a model smallpox vaccination clinic.) |
view (953 KB/48 pages) |
view (740 KB/48 pages) |
|
Annex 4—Vaccine Adverse-Event Reporting (Vaccine Safety: Monitoring and Reporting of Adverse Events Following Smallpox Vaccination) |
view (304 KB/19 pages) |
view (283 KB/19 pages) |
|
Annex 5—Suggested Pre-Event Planning Activities for State & Local Health Authorities | view (492 KB/28 pages) |
view (245 KB/28 pages) |
|
Generalized Vesicular or Pustular Rash Illness Protocol color | view (78 KB/1 page) |
||
Generalized Vesicular or Pustular Rash Illness Protocol black & white | view (129 KB/1 page) |
||
Annex 6—Data Management | |||
Part 1—Smallpox Response System Requirements | view (315 KB/9 pages) |
view (169 KB/9 pages) |
|
Part 2—Data Exchange Format Requirements | view (763 KB/21 pages) |
view (373 KB/21 pages) |
|
Part 3—Smallpox Post-Event Response Outbreak Management System (OMS) | view (874 KB/10 pages) |
view (1.80 MB/10 pages) |
|
Annex 7—Forms in development | view (25 KB/2 pages) |
view (249 KB/2 pages) |
|
Annex 8—Checklists for State/Local/CDC Personnel Actions in a Smallpox Emergency | view (292 KB/7 pages) |
view (179 KB/7 pages) |
|
Annex 9 | Coming soon | Coming soon | |
Annex 10 (formerly Annex 6)—Glossary of Abbreviations and Smallpox References | view (90 KB/3 pages) |
view (31 KB/3 pages) |
|
- Page last reviewed February 6, 2007
- Page last updated June 23, 2004
- Content source: Division of Bioterrorism Preparedness and Response (DBPR), National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Office of Infectious Diseases
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO